Skip to main content

previous disabled Page of 2
and
  1. Article

    Open Access

    Two single lung transplantations from one donor: lung twinning in the LAS era

    The implementation of the Lung Allocation Score (LAS) in the Eurotransplant international collaborative framework decreased waiting list mortality, but organ shortage remains a significant problem. Transplanta...

    Frank Langer, Philipp M. Lepper, Bettina Weingard, Parviz Aliyev in Respiratory Research (2024)

  2. Article

    Open Access

    Machine learning assisted feature identification and prediction of hemodynamic endpoints using computed tomography in patients with CTEPH

    Chronic thromboembolic pulmonary hypertension (CTEPH) is a rare but potentially curable cause of pulmonary hypertension (PH). Currently PH is diagnosed by right heart catheterisation. Computed tomography (CT) ...

    Joshua Gawlitza, Sophie Endres, Peter Fries in The International Journal of Cardiovascula… (2024)

  3. No Access

    Article

    Kommentar zu den Leitlinien (2022) der ESC/ERS zur Diagnostik und Behandlung der pulmonalen Hypertonie

    Die pulmonale Hypertonie (PH) ist ein häufiges Phänomen, das bei ca. 1 % der Bevölkerung auftritt und das unabhängig von der zugrunde liegenden Ursache mit einer erheblichen Morbidität und Mortalität einhergeh...

    Prof. Dr. Stephan Rosenkranz, Stefan Frantz, Daniel Dumitrescu in Die Kardiologie (2024)

  4. Article

    Open Access

    Outcome of lung transplant recipients infected with SARS-CoV-2/Omicron/B.1.1.529: a Nationwide German study

    Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) is currently the major threat for immunocompromised individuals. The course of COVID-19 in lung t...

    Nikolaus Kneidinger, Matthias Hecker, Vasiliki Bessa, Ina Hettich in Infection (2023)

  5. Article

    Interventionelle Therapie und multidisziplinäre Managementstrategien für die akute Lungenembolie

    Die interventionelle Therapie der akuten Lungenembolie bietet großes Potenzial zur Senkung von Morbidität und Mortalität ausgewählter Patientinnen und Patienten mit intermediär-hohem und hohem Risiko. In diese...

    Prof. Dr. Alexander Ghanem, Martin Andrassy, Daniel Dürschmied in Die Kardiologie (2023)

  6. Article

    Open Access

    YouTube-videos for patient education in lymphangioleiomyomatosis?

    The Internet is commonly used by patients to acquire health information. To date, no studies have evaluated the quality of information available on YouTube regarding lymphangioleiomyomatosis (LAM). Our aim was...

    Finn M. Wilkens, Claudia Ganter, Katharina Kriegsmann in Respiratory Research (2022)

  7. No Access

    Article

    The Phagocytosis of Blood Leukocytes from Cystic Fibrosis Patients is not Impaired in General

    Impaired phagocytosis of Pseudomonas aeruginosa was found in isolated monocytes of peripheral blood of cystic fibrosis patients, but not in their neutrophils, as reported some years ago. In the present study, we ...

    Laura Leuer, Angelika Krill, Heinrike Wilkens, Gudrun Wagenpfeil, Markus Bischoff in Lung (2020)

  8. No Access

    Chapter

    Akute und chronische Lungenembolie

    Die akute Lungenembolie ist ein häufiges Krankheitsbild, das weitreichende Konsequenzen für die betroffenen Patienten haben kann. Neben der signifikanten Gefahr einer akuten Rechtsherzdekompensation mit hoher ...

    Heinrike Wilkens, Hans-Joachim Schäfers in Kompendium der modernen Herzchirurgie beim… (2020)

  9. Article

    Open Access

    Incidence and characteristics of chronic thromboembolic pulmonary hypertension in Germany

    The incidence of chronic thromboembolic pulmonary hypertension (CTEPH) is unknown. Previous studies from the United Kingdom and Spain have reported incidence rates of 1.75 and 0.9 per million, respectively. Th...

    Thorsten Kramm, Heinrike Wilkens, Jan Fuge in Clinical Research in Cardiology (2018)

  10. No Access

    Article

    Anxiety, Depression, and Health-Related QOL in Patients Diagnosed with PAH or CTEPH

    Pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH) are life-threatening diseases with a high burden of symptoms. Although depression, anxiety, and reduced health re...

    Elena Pfeuffer, Holger Krannich, Michael Halank, Heinrike Wilkens, Philipp Kolb in Lung (2017)

  11. Article

    Open Access

    Efficacy and safety of nasal high-flow oxygen in COPD patients

    Nasal high-flow oxygen therapy (HFOT) is a novel treatment option for patients suffering from acute or chronic respiratory failure. Aim of our study was to compare safety and efficacy of HFOT with those of con...

    Helene Vogelsinger, Michael Halank, Silke Braun, Heinrike Wilkens in BMC Pulmonary Medicine (2017)

  12. Article

    Open Access

    Late outcomes after acute pulmonary embolism: rationale and design of FOCUS, a prospective observational multicenter cohort study

    Acute pulmonary embolism (PE) is a frequent cause of death and serious disability. The risk of PE-associated mortality and morbidity extends far beyond the acute phase of the disease. In earlier follow-up stud...

    Stavros V. Konstantinides, Stefano Barco in Journal of Thrombosis and Thrombolysis (2016)

  13. Article

    Open Access

    The role of circulating thrombospondin-1 in patients with precapillary pulmonary hypertension

    The vasoconstrictive protein TSP-1 is released from endothelial cells upon increased shear stress and hypoxia. Both conditions are prevalent in pulmonary hypertension (PH). TSP-1 damages the local microcircula...

    Ralf Kaiser, Christian Frantz, Robert Bals, Heinrike Wilkens in Respiratory Research (2016)

  14. Article

    Open Access

    Runtime and aPTT predict venous thrombosis and thromboembolism in patients on extracorporeal membrane oxygenation: a retrospective analysis

    Even though bleeding and thromboembolic events are major complications of extracorporeal membrane oxygenation (ECMO), data on the incidence of venous thrombosis (VT) and thromboembolism (VTE) under ECMO are s...

    Franziska C. Trudzinski, Peter Minko, Daniel Rapp in Annals of Intensive Care (2016)

  15. No Access

    Article

    MR-proADM Predicts Exercise Capacity and Survival Superior to Other Biomarkers in PH

    Besides the established biomarker NT-proBNP, the new cardiovascular biomarkers MR-proANP, MR-proADM, Copeptin, and CT-proET-1 are promising to evaluate hemodynamics, exercise parameters, and prognosis in pati...

    Martin Kolditz, Hans-Jürgen Seyfarth, Heinrike Wilkens, Ralf Ewert, Tom Bollmann in Lung (2015)

  16. Article

    Open Access

    A symptom-related monitoring program following pulmonary embolism for the early detection of CTEPH: a prospective observational registry study

    Chronic thromboembolic pulmonary hypertension (CTEPH) is a long-term complication following an acute pulmonary embolism (PE). It is frequently diagnosed at advanced stages which is concerning as delayed treatm...

    Matthias Held, Alexander Hesse, Franziska Gött, Regina Holl in BMC Pulmonary Medicine (2014)

  17. No Access

    Article

    Economic Evaluation of Exercise Training in Patients with Pulmonary Hypertension

    Exercise training as an add-on to medical therapy has been shown to improve exercise capacity, quality of life, and possibly prognosis in patients with pulmonary hypertension (PH). The purpose of this study wa...

    Nicola Ehlken, Cora Verduyn, Henning Tiede, Gerd Staehler, Gabriele Karger in Lung (2014)

  18. No Access

    Article

    Exercise Capacity Affects Quality of Life in Patients with Pulmonary Hypertension

    The objective of this prospective study was to evaluate the impact of exercise capacity, mental disorders, and hemodynamics on quality-of-life (QoL) parameters in patients with pulmonary arterial hypertension ...

    Michael Halank, Franziska Einsle, Stephanie Lehman, Hinrich Bremer, Ralf Ewert in Lung (2013)

  19. Article

    Open Access

    Long-term effects of intravenous iloprost in patients with idiopathic pulmonary arterial hypertension deteriorating on non-parenteral therapy

    The majority of patients with idiopathic pulmonary arterial hypertension (IPAH) in functional classes II and III are currently being treated with non-parenteral therapies, including endothelin receptor antagon...

    Lars Knudsen, Alexander Schurawlew, Nils Nickel, Henning Tiede in BMC Pulmonary Medicine (2011)

  20. No Access

    Article

    Progrediente Dyspnoe eines Hufschmieds — EAA und rezidivierende Rauchgas-Inhalationen als seltene Ursache

    Es wird ein 47-jähriger Patient mit progredienter Dyspnoe und produktivem Husten infolge einer exogen-allergischen Alveolitis beschrieben. Ätiologisch konnte diese Hypersensitivitätspneumonitis — durch Nachwei...

    Michaela Mittmann-Frank, Bianca Karabin-Kehl in Zentralblatt für Arbeitsmedizin, Arbeitssc… (2011)

previous disabled Page of 2